Structure Correlated Parameters and Their Influence on the Bioactivity of Compounds

• Autorzy: Persona M. , Gęca T. , Persona A. , Richtr V. , Kraitr M.
• Konferencja: 10th Ukrainian-Polish Symposium "Theoretical and Experimental Studies of Interfacial Phenomena and Their Technological Applications", Lviv-Uzlissja, Ukraine
• Języki publikacji: EN

Abstrakty

EN

The skin barrier function is important both to the topical delivery of drugs and to risk assessment following dermal exposure to various chemicals. It is impossible to assess the skin permeability of all new molecules synthesized in laboratory using only in vivo experiments. Computationalmodeling and QSAR methods provide an inexpensive and fast way to assess the potential for skin permeability of molecule before synthesis and enables prioritization of molecules for in vitro and in vivotests. To illustrate the possibility of the use of calculation methods to estimate the skin permeability of compounds a congeneric series of triterpenes was chosen.

Słowa kluczowe

EN

skin permeability; structure-activity; triterpenes

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Polish Journal of Chemistry
• Rocznik: 2008
• Tom: Vol. 82, nr 1-2
• Strony: 241--247
• Opis fizyczny: Bibliogr. 41 poz., rys.

Twórcy

autor

Persona M.

autor

Gęca T.

autor

Persona A.

autor

Richtr V.

autor

Kraitr M.

• Faculty of Mathematics and Natural Science, The John Paul II Catholic University of Lublin, Lublin, Poland,

Bibliografia

• 1. Perkins M.A., Osborne R. And Johnson G.R., Fundam. Appl. Toxicol., 31,9 (1995).
• 2. Zdziesinska Z., Rzeski W., Paduch R., Szuster-Ciesielska A., Kaczor J., Wejksza K. and Kandefer-Szerszeń M., Pol. J. Pharmacol., 55, 235 (2003).
• 3. Vidya L., Ma Jini M.M. and Yara Jakshmi R, Pharm. Res., 42, 4 (2000).
• 4. Kitagawa S., Hosokai A., Kaseda Y., Yamamoto N., Kaneko Y. and Matsuoka E., Int. J. Pharm. ,161,115 (1998).
• 5. Kvasnica M., Sarek J., Klinotova E., Dzubak P. and Hajduch M., Bioorg. Med Chem., 13,3447 (2005).
• 6. Fleghter O.B., Boreko E.I., Nigmatullina L.R., Pavlova N.J., Medvedeva N.J., Nikolaeva S.N., Ashavina O.A., Savinova N.J., Baltina L.A., Galin F.Z. and Tolsikov G.A., Pharm. Chem. J., 38, 355 (2004).
• 7. Liu W.K, Ho J.C., Cheung F.W., Liu B.P., Ye W.C. and Che C.T., Eur. J. Pharmacol., 498,71 (2004).
• 8. Lutskii V.L, Gromova A.S., Khamidullina E.A. and Owen N.L., Chem. Nat. Compd., 41, 117 (2005).
• 9. Zuco V., Supico R., Righetti S.C., Cleris L., Marchesi E., Gambacorti-Passerini C. and Formelli F., CancerLett., 175, 17(2002).
• lO. Hiroya K., Takahashi T., Miura N., Naganuma A. and Sakamoto T., Bioorg. Med. Chem., 10, 3229 (2002).
• ll. Malini M.M., Lenin M. and Varalakshmi P., Pharmacol. Res., 41, 413 (2000).
• 12. Mdnez S., Recio M.C., Giner R.M. and Rios J.L., Eur. J. Pharmacol., 334, 103 (1997).
• 13. Flekhter O.B., Karachurina L.T., Poroikov V.V., Nigmatullina L.R., Baltina L.A., Zarudii F.S., Davydowa V.A., Spirikhin L. V., Baikova I.P., Galin F.Z. and Tolsikov G.A., Bioorg. Khim., 26(3), 215 (2000)
• 14. Leo A. and Hansh C.,Perspective Drug Discov., 17, l (1999).
• 15. Cronin M.T.D., Dearden J.C., Dufly J.C., Edwards R., Manga N., Worth A.P. and Worgan A.D.P., SAR QSAR Environ. Res., 13, 167 (2002).
• 16. Jóźwiak K., Szumiło H. and Soczewiński E., Wiad. Chem., 55, 1047 (2001).
• 17. Sangster J., Octanol-Water Partition Coefficients: Fundamentals and Physical Chemistry, Wiley, Chichester 1997.
• 18. Leo A., Chem. Rev., 93, 1281 (1993).
• 19. Leo A., Hansh C. and Elkins D., Chem. Rev., 71, 525 (1971).
• 20. Hansh C. and Leo A., Substituent Constants for Correlation Analysis in Chemistry and Biology, Wiley, New York 1979.
• 21. Rekker R.F., The Hydrophobic Fragment Constant, Elsevier, New York 1977.
• 22. Suzuki T. and Kudo Y, J. Comput.-Aided Mol. Des., 4, 155 (1990).
• 23. Moriguchi L, Hirono S., Liu Q., Nakome I. and Matsushita Y, Chem. Pharm. Bull., 40, 127 (1992).
• 24. Kloppman G. and Wang S., Chem. Pharm. Bull., 12, 1025 (1991).
• 25. Kloppman G., Li J-Y, Wang S. and Dimayuga M., J. Chem. Inf. Comput. Scl, 34, 752 (1994).
• 26. Broto R, Moreau G. and Vandycke C., Eur. J. Med. Chem., 19, 71 (1984).
• 27. Ghose A.K. and Crippen G.M., J. Comput. Chem., 1, 565 (1986).
• 28. Ghose A.K., Pritchett A. and Crippen G.M., J. Comput. Chem., 9, 80 (1988).
• 29. Visvanadhan V.N., Ghose A.K., Revankar G.R. and Robins R.K., J. Chem. Inf. Comput. Sci., 29, 163 (1989).
• 30. Tetko J.V., Tanchuk V.Y. and Villa E.R, ibid., 41, 1407 (2001).
• 31. Tetko J.V. and Tanchuk V.Y, ibid, 42, 1136 (2002).
• 32. Miller J.C. and Miller J.N., Statistics for Analytical Chemistry. 3rd ed., Ellis Horwood Prentice Hali, New York 1993.
• 33. http://www.vcclab.org
• 34. Hadgraft J., Int. J. Pharm., 224, l (2001).
• 35. Hadgraft J., Eur. J. Pharm. Biopharm., 58, 291 (2004).
• 36. Fitzpatrick D., Corish J. and Hayes B., Chemosphere, 55, 1309 (2004).
• 37. Barratt M.D., Toxicol in Vitro, 9, 27 (1995).
• 38. Pugh W.J., Tuncer Degim J. and Hadgraft J., Int. J. Pharm., 197, 203 (2000).
• 39. Kasting G.B. and Robinson P.J., Pharm. Res., 10, 930 (1993).
• 40. Alakurtti S., Makela T, Koskimies S. and Yli-Kauhaluoma J., Eur. J. Pharm. Sci., 29, l (2006).
• 41. Huguet A.I., del Carmen Recio M., Manez S., Giner R.M. and Rios J.L., Eur. J. Pharmacol., 410, 69 (2000).